PCSK9 and metabolic dysfunction-associated steatotic liver disease: Indeed, pre-clinical and clinical data have highlighted a potential link between PCSK9 and NAFLD, demonstrating that circulating PCSK9 can prevent hepatic lipid uptake and accumulation.